CLOV vs HBIO · rev $1.37B vs rev $86.5M
Clover Health Investments Corp (CLOV) versus Harvard Bioscience Inc (HBIO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported HBIO revenue for 2025-12-31 was $86.5M. Net income was -$56.7M. Revenue was down 8.1% from 2024-12-31 to 2025-12-31. HBIO currently screens at market cap $20.3M.
CLOV currently screens at market cap $1.55B. HBIO currently screens at market cap $20.3M.
Not investment advice. Open the CLOV and HBIO stock pages for the full models.
Not investment advice.